
IPNET newsletter, december 2025
Dear all Ipnet members, It is a great pleasure for Ipnet to circulate the December 2025 issue of the Ipnet Newsletter. Enjoy your reading and feel free to distribute !
Ipnet, the International Porphyria Network, is a non-profit learned association (or scientific association), having its office in Innsbruck, Austria.
Ipnet will promote fundamental and clinical research in the field of porphyrias, improve knowledge of the porphyrias and facilitate best practice in their treatment and diagnosis by accommodating and interconnecting expert activities across the world in the service of porphyria patients.

Dear all Ipnet members, It is a great pleasure for Ipnet to circulate the December 2025 issue of the Ipnet Newsletter. Enjoy your reading and feel free to distribute !

Refer a patient:We offer support to clinicians looking after patients with suspected or confirmed porphyria in countries where expert advice is not available. We can help with laboratory testing, interpretation

The International Congress of Porphyrins and Porphyrias took place on September 21-25, 2024 in Pamplona, Spain, bringing together clinicians, researchers, scholars, patients and their families for three days networking and
Here you’ll find clear, practical information about porphyria—what it is, how different types can affect you, and what symptoms to watch for. We also cover diagnosis, treatment options, everyday management, and safety topics like medications and skin protection. Use these pages to better understand your condition and to support conversations with your healthcare team.
This area provides clinically focused resources on the porphyrias, including current diagnostic pathways, laboratory testing, family investigation, and management of acute attacks. You’ll also find guidance on drug safety and specific disease entities such as PCT and erythropoietic protoporphyria. The content is intended to support evidence-based decision-making in everyday practice.
An international network of experts working together to improve healthcare services for porphyria patients
Postal adress
c/o studio12 gmbh
Kaiser-Josef-Straße 9
6020 Innsbruck, Austria
Registered adress
NAPOS, Department of Medical Biochemistry and Pharmacology (MBF)
Haukeland Universitetssykehus, P.O. Box 1400
5021 Bergen, Norway
© 2026 IPNET - all rights reserved